U.S. FDA Authorized E-Cigarette List Explained: 39 Legal Products and Industry Insights

 U.S. FDA Authorized E-Cigarette List Explained: 39 Legal Products and Industry Insights

The U.S. Food and Drug Administration (FDA), under the Family Smoking Prevention and Tobacco Control Act (established in 2009), created the PMTA (Premarket Tobacco Product Application) framework. Through this scientific review system, FDA evaluates whether e-cigarettes provide harm reduction value for adult smokers while minimizing risks to non-smokers, particularly youth, in order to determine if a product is “Appropriate for the Protection of Public Health” (APPH).
Only products that pass the PMTA review with sufficient scientific evidence are legally permitted to be marketed in the United States.

I. FDA-Authorized E-Cigarette Products as of August 2025

JUUL Labs Inc.

• JUUL Device

• JUULpods: Virginia Tobacco 3%, Virginia Tobacco 5%, Menthol 3%, Menthol 5%

Logic Technology Development LLC

• Logic Regular Cartridge/Capsule Package

• Logic Pro Capsule Tank System (1) & (2)

• Logic Vapeleaf Cartridge/Capsule Package

• Logic Vapeleaf Tobacco Vapor System

• Logic Pro Tobacco e-Liquid Package

• Logic Power Tobacco e-Liquid Package

• Logic Power Rechargeable Kit

NJOY LLC

• NJOY DAILY – Rich Tobacco 4.5%, Menthol 4.5%

• NJOY DAILY EXTRA – Rich Tobacco 6%, Menthol 6%

• NJOY ACE Device

• NJOY ACE POD – Classic Tobacco 2.4% / 5%, Rich Tobacco 5%, Menthol 2.4% / 5%

R.J. Reynolds Vapor Company (Vuse Series)

• Vuse Solo Power Unit

• Vuse Replacement Cartridge – Original 4.8% G1 & G2

• Vuse Vibe Power Unit (1) & (2)

• Vuse Vibe Tank – Original 3.0%

• Vuse Alto Power Unit

• Vuse Alto Pod – Golden Tobacco 1.8%, 2.4%, 5%; Rich Tobacco 1.8%, 2.4%, 5%

• Vuse Ciro Power Unit (1) & (2)

• Vuse Ciro Cartridge – Original 1.5%

In total, 39 e-cigarette products have been authorized by the FDA.

II. The Significance and Challenges Behind Authorization

1. Scientific Review and Public Health Standards
In its PMTA evaluation, the FDA focuses on whether a product:

• Helps transition adult smokers from combustible cigarettes to e-cigarettes, thereby reducing tobacco-related harm;

• Does not increase exposure and addiction risks among non-smokers, particularly youth.

2. Limitations in Product Types and Flavors

• Although 39 products are on the list, truly distinct hardware devices account for only about 6–7 models;

• Most are variations of pods with different nicotine strengths or flavors;

• Authorized flavors are limited to tobacco and menthol, excluding fruit, dessert, and open-system devices that are popular among consumers.

3. Risks of Unauthorized Products

• Selling e-cigarettes not authorized by the FDA is illegal in the U.S.;

• Popular fruit-flavored disposables such as Elf Bar, which lack FDA authorization, have already faced enforcement warnings.

III. iPure’s Industry Response Strategy

Guided by the principle of compliance as the core value, iPure will:

• Continuously monitor FDA authorization updates and regulatory developments;

• Proactively develop devices and e-liquids that meet PMTA standards;

• Strengthen user education, promoting lawful consumption and proper purchasing channels;

• Drive product innovation and quality enhancement to ensure sustainable competitiveness.

IV. Conclusion: Compliance as Responsibility

Although the FDA’s authorized list includes 39 products, the majority are variations of pods or cartridges, with limited hardware options available. Regulators remain cautious in balancing harm reduction for adult smokers with preventing youth uptake.

At iPure, we are committed to advancing e-liquid innovation under full compliance, providing users with safe, high-quality products. We believe that with proper regulation, the industry can achieve sustainable and healthy development.

Disclaimer

This article is based on publicly available information from the FDA and third-party sources, and is provided for reference only. iPure does not assume responsibility for the completeness or accuracy of policy content. Readers should refer to official FDA documents for authoritative information.

Reprint Statement

This article is an original work by iPure. Reproduction or citation is welcome with proper attribution. Unauthorized commercial use or modification is prohibited, and iPure reserves the right to pursue legal action.